Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas

NCT03786926 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
53
Enrollment
INDUSTRY
Sponsor class

Stopped 2018-689-00US1 has been halted by HUTCHMED based on strategic evaluation of the clinical development of HMPL-689 in the United States, Europe, and Australia.

Conditions

Interventions

Sponsor

Hutchmed